AU Patent

AU2021204313A1 — Modulation of complement activity

Assigned to UCB Holdings Inc · Expires 2021-07-22 · 5y expired

What this patent protects

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics. 10838884_1 (GHMatters) P104653.AU.1 14/11/18

USPTO Abstract

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics. 10838884_1 (GHMatters) P104653.AU.1 14/11/18

Drugs covered by this patent

Patent Metadata

Patent number
AU2021204313A1
Jurisdiction
AU
Classification
—
Expires
2021-07-22
Drug substance claim
No
Drug product claim
No
Assignee
UCB Holdings Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.